Faculty profile

Howard Chertkow

ResearcherMedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Howard Chertkow

Researcher

Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
33 publications in the last five years, latest in 2026.
Senior (last) author on 9 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2023.
Supervised 1 trainee who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

358

Citations

h-index

149

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Dementia Diagnosis Prevention Biomarkers Brain Imaging Cognition Edi Indigenous Cognitive Health

Latest papers

Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodies.
Journal of biomedical science · 2026
Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment.
Journal of the neurological sciences · 2026 · senior author
Examining the effects of alcohol use on verbal memory processes in older adults with mild cognitive impairment.
Journal of Alzheimer's disease : JAD · 2026

All 51 publications

Latest funding

Evaluating the feasibility and efficacy of a community-based approach toward personalized dementia risk reduction
CIHR · 2024 · Supervisor
$140,000
Canadian Consortium on Neurodegeneration in Aging: Application for Phase III CCNA Operations Centre
CIHR · 2023 · Nominated PI
$20,555,200
COVID-19 Variant Supplement - Implementation of serological and molecular tools to inform COVID-19 patient management
CIHR · 2021 · Co-investigator
$50,000

All 7 grants and awards

51 publications.

Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodies.

Delva A, Joza S, Tremblay C, Vo A, Filiatrault M, Carrier M, Taylor JP, O'Brien JT, Firbank M, Thomas A, Donaghy PC, Camicioli R, Chertkow H, Dagher A, Postuma RB, Rahayel S

Journal of biomedical science2026

DOI: 10.1186/s12929-026-01267-6 PMID: 42265698

Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment.

Lahiri D, Kathir S, Punjwani Z, Liu A, Pasvanis S, Seixas-Lima B, Roncero CT, Chertkow H, COMPASS-ND investigators

Journal of the neurological sciences2026Senior author

DOI: 10.1016/j.jns.2026.126047 PMID: 42275797

Examining the effects of alcohol use on verbal memory processes in older adults with mild cognitive impairment.

Cuperfain AB, Pishdadian S, Binns MA, Black SE, Chertkow H, Freedman M, Louis J, Ma C, Masellis M, Mclaughlin PM, Ramirez J, Tang-Wai DF, Tartaglia MC, Kumar S, CCNA COMPASS-ND Group, and on behalf of the ONDRI Group

Journal of Alzheimer's disease : JAD2026

DOI: 10.1177/13872877261444995 PMID: 42033405

Reference data and clustering of lifestyle-based dementia risk factor scales among older Canadian adults.

D'Amico D, Tan B, Nandlall K, Binns M, Chertkow H, Anderson ND

Experimental gerontology2026

DOI: 10.1016/j.exger.2026.113114 PMID: 41905661

The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) Study Neuropsychology Battery of the Canadian Consortium on Neurodegeneration in Aging (CCNA): Battery Development and Description.

Phillips NA, Fogarty J, Pilon R, Whitehead V, Best S, DiProspero C, Fouquet C, Beuk J, Mohades Z, Das S, Beaudoin C, Henri-Bellmare C, Anderson N, Belleville S, Brambati S, Einstein G, McLaughlin P, Chertkow H, Borrie M

Canadian journal on aging = La revue canadienne du vieillissement2026

DOI: 10.1017/s0714980825100330 PMID: 41277695

Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact.

Seixas-Lima B, Rosa-Neto P, Phillips NA, Borrie M, Roncero CT, Lahiri D, Dori D, Eintracht S, Chertkow H

Journal of Alzheimer's disease : JAD2026Senior author

DOI: 10.1177/13872877251401611 PMID: 41358624

The Relationship between Age and Cognitive Subtypes of Alzheimer Syndrome and Related Dementias.

Seixas-Lima B, Binns M, Black SE, Freedman M, Kumar S, Lahiri D, Roncero CT, Strother S, Tang-Wai DF, Tartaglia MC, Chertkow H

Dementia and geriatric cognitive disorders2026Senior author

DOI: 10.1159/000547124 PMID: 40587959

Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.

Joza S, Delva A, Tremblay C, Vo A, Filiatrault M, Tweedale M, Gagnon JF, Postuma RB, Dagher A, Klein J, Hu M, Dusek P, Marecek S, Varga Z, Taylor JP, O'Brien JT, Firbank M, Thomas A, Donaghy PC, Lehéricy S, Isabelle Arnulf, Vidailhet M, Corvol JC, Iceberg Study Group, Camicioli R, Chertkow H, Lewis S, Matar E, Ehgoetz Martens KA, Churchill L, Sommerauer M, Röttgen S, Borghammer P, Knudsen K, Hansen AK, Arnaldi D, Orso B, Mattioli P, Roccatagliata L, Monchi O, Rahayel S

EBioMedicine2025

DOI: 10.1016/j.ebiom.2025.105753 PMID: 40447483

Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline.

Dori D, Seixas-Lima B, Roncero C, Lahiri D, Borrie M, Chertkow H

Alzheimer's & dementia : the journal of the Alzheimer's Association2025Senior author

DOI: 10.1002/alz.70960 PMID: 41400007

Exploring the usability and perceived benefits of Brain Health PRO: An online educational program for healthy brain aging.

Philip G, Fiocco AJ, Belleville S, Chertkow H, Feldman HH, Montero-Odasso M, Nygaard HB, Savundranayagam MY, Canadian Consortium on Neurodegeneration in Aging (CCNA), CAN-THUMBS UP Study Group

Digital health2025

DOI: 10.1177/20552076251395585 PMID: 41278371

Evaluating the feasibility and efficacy of a community-based approach toward personalized dementia risk reduction

SupervisorCIHR2024CIHR Fellowship

Principal investigators: D'Amico, Danielle N

Keywords: Aging; Brain Health; Cognitive Aging; Cognitive Function; Community-Based Program; Dementia Risk Factors; Dementia Risk Reduction; Health Promotion; Lifestyle Behaviours; Program Evaluation

$140,000

Canadian Consortium on Neurodegeneration in Aging: Application for Phase III CCNA Operations Centre

Nominated PICIHR2023Canadian Consortium on Neurodegeneration in Aging

Principal investigators: Chertkow, Howard M; Anderson, Nicole D; Andrew, Melissa K; Badhwar, Amanpreet; Belleville, Sylvie N; Bethell, Jennifer M; Bhangu, Jaspreet S; Black, Sandra E; Borrie, Michael J; Brewster, Paul W; Camicioli, J. Richard M; Crowshoe, Lynden L; Darvesh, Sultan; DeMarco, Mari; Dixon, Roger A; Duchesne, Simon; Einstein, Gillian; Evans, Alan C; Feldman, Howard; Fisk, John D; Geddes, Maiya R; Lim, Andrew S; Masellis, Mario; McAiney, Carrie A; Mclaurin, Joanne; Montero Odasso, Manuel M; Nygaard, Haakon B; O'Connell, Megan E; Phillips, Natalie A; Rajah, Maria N; Roach, Pamela Marie; Robillard, Julie; Rockwood, Kenneth; Smith, Eric E; Villeneuve, Sylvia C; Waldron, Ingrid R; Walker, Jennifer

Keywords: Biomarkers; Brain Imaging; Cognition; Dementia; Diagnosis; Edi; Indigenous Cognitive Health; Knowledge Mobilization; Prevention; Risk Factors

$20,555,200

COVID-19 Variant Supplement - Implementation of serological and molecular tools to inform COVID-19 patient management

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 1

Principal investigators: Lerner-Ellis, Jordan P; Taher, Jennifer

Keywords: Antibody; Covid-19; Genomes; Genomics; Immunity; Infection; Sars-Cov-2; Serology; Susceptibility; Virus

$50,000

COVID-19 Variant Network - Implementation of serological and molecular tools to inform COVID-19 patient management

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 2

Principal investigators: Lerner-Ellis, Jordan P; Taher, Jennifer

Keywords: Antibody; Covid-19; Genomes; Genomics; Immunity; Infection; Sars-Cov-2; Serology; Susceptibility; Virus

$100,000

Implementation of serological and molecular tools to inform COVID-19 patient management

Co-investigatorCIHR2020Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

Principal investigators: Lerner-Ellis, Jordan P; Taher, Jennifer

Keywords: Antibody; Covid-19; Genomes; Genomics; Immunity; Infection; Sars-Cov-2; Serology; Susceptibility; Virus

$2,067,198

Phase Two of the Canadian Consortium on Neurodegeneration in Aging

Nominated PICIHR2019Canadian Consortium on Neurodegeneration in Aging

Principal investigators: Chertkow, Howard M; Anderson, Nicole D; Andrew, Melissa K; Bartha, Robert; Bellec, Pierre; Belleville, Sylvie N; Bergman, Howard; Bherer, Louis; Black, Sandra E; Borrie, Michael J; Camicioli, J. Richard M; Carrier, Julie; Cashman, Neil R; Collins, Donald L; Cuello, A. Claudio G; Dixon, Roger A; Ducharme, Simon; Duchesne, Simon; Einstein, Gillian; Eintracht, Shaun; Evans, Alan C; Fahnestock, Margaret; Feldman, Howard; Ferland, Guylaine; Fisk, John D; Gan-Or, Ziv; Giguère, Anik; Herrmann, Nathan; Hsiung, Ging-Yuek R; Lanctôt, Krista L; Lim, Andrew S; Mackenzie, Ian R; Masellis, Mario; Maxwell, Colleen J; McGilton, Katherine S; Mclaurin, Joanne; Montero Odasso, Manuel M; Morgan, Debra G; Naglie, Gary; Nygaard, Haakon B; O'Connell, Megan E; Phillips, Natalie A; Poirier, Judes; Rapoport, Mark J; Robillard, Julie; Rockwood, Kenneth; Rogaeva, Ekaterina; Rosa-Neto, Pedro; Rylett, Jane R; Seitz, Dallas P; Siminovitch, Katherine A; Smith, Eric E; ST GEORGE-HYSLOP, Peter H; Vedel, Isabelle; Walker, Jennifer; Wittich, Walter

Keywords: Alzheimer Disease; Dementia; Diagnosis; Prevention; Quality Of Life; Sex; Treatment

$31,625,000

Understanding Neurodegeneration, Venules, Amyloid Imaging and Leukoaraiosis (UNVAIL)

Principal investigatorCIHR2016Project Grant

Principal investigators: Black, Sandra E; Bocti, Christian; Borrie, Michael J; Chertkow, Howard M; Darvesh, Sultan; Dowlatshahi, Dariush; Frayne, Richard; Hsiung, Ging-Yuek R; Laforce, Robert J; Mandzia, Jennifer L; Masellis, Mario; Prato, Frank S; Sahlas, Demetrios; Smith, Eric E; Soucy, Jean-Paul; Strother, Stephen; Swartz, Richard

Keywords: Amyloid And Tau Pet Imaging; Amyloid Angiopathy; Brain Volumetrics And Microstructural Integrity; Executive Dysfunction And Memory Loss; Executive Function Processing; Metabolic Imaging And Functional Networks; Small Vessel Disease; Stroke And Transient Ischemic Attack; Subcortical Ischemic Brain Small Blood Vessel Disasculopathy; Venous Collagenosis

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Howard Chertkow

Research

Latest papers

Latest funding

Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodies.

Application of a clinical scale for predicting A&#x3b2;-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment.

Examining the effects of alcohol use on verbal memory processes in older adults with mild cognitive impairment.

Reference data and clustering of lifestyle-based dementia risk factor scales among older Canadian adults.

The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) Study Neuropsychology Battery of the Canadian Consortium on Neurodegeneration in Aging (CCNA): Battery Development and Description.

Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact.

The Relationship between Age and Cognitive Subtypes of Alzheimer Syndrome and Related Dementias.

Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.

Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline.

Exploring the usability and perceived benefits of Brain Health PRO: An online educational program for healthy brain aging.

Evaluating the feasibility and efficacy of a community-based approach toward personalized dementia risk reduction

Canadian Consortium on Neurodegeneration in Aging: Application for Phase III CCNA Operations Centre

COVID-19 Variant Supplement - Implementation of serological and molecular tools to inform COVID-19 patient management

COVID-19 Variant Network - Implementation of serological and molecular tools to inform COVID-19 patient management

Implementation of serological and molecular tools to inform COVID-19 patient management

Phase Two of the Canadian Consortium on Neurodegeneration in Aging

Understanding Neurodegeneration, Venules, Amyloid Imaging and Leukoaraiosis (UNVAIL)

Frequent collaborators

Howard Chertkow

Howard Chertkow

Manuel Montero Odasso

Michael Borrie

Sanjeev Kumar

Zahinoor Ismail

Pedro Rosa-Neto

Jean-Paul Soucy

Serge Gauthier

Robert Laforce

Mario Masellis

Malcolm Binns

Serge Gauthier

Natalie Phillips

Simon Ducharme

Linda Lee

Jean-Claude Tardif

Linda Lee

Sandra Black

Robert Bartha

Katherine Zukotynski

Demetrios Sahlas

Nathan Herrmann

Kenneth Rockwood

Jean-Claude Tardif

Tony Mazzulli

Marie Filiatrault

Maged Goubran

Jennifer Taher

Dallas Seitz

Gillian Einstein

Saskia Sivananthan

Mark Speechley

Ekaterina Rogaeva

Louis Bherer

Andrew Frank

Megan O'Connell

Anne-Claude Gingras

Michael Noseworthy

Stephen Strother

Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment.